G3BP1 and nasopharyngeal carcinoma: To determine whether DCAF7 is involved in the degradation of G3BP1 via either the ubiquitin‒proteasome pathway or the autophagy–lysosomal pathway, NPC cells were exposed to a proteasome inhibitor (MG132) or a lysosome inhibitor (chloroquine; CQ).